A surgical mesh company claims the FDA improperly called one of its products’ safety into question.
The agency said [recently] that two surgical mesh brands used off-label in breast reconstruction surgery have had “significantly higher major complication rates.”
Read the full article at www.medicaldesignandoutsourcing.com
